$THC
TENET HEALTHCARE CORP Stock $thc

$thc Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000007031821000040 Filed on October 29, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q3
Revenue	$4.856B	$4.894B	$4.557B
YoY Change	-1.2%	7.4%	-0.24%
Cost Of Revenue	$838.0M	$827.0M	$784.0M
YoY Change	1.7%	5.48%	3.16%
Gross Profit	$4.018B	$4.067B	$3.773B
YoY Change	-1.78%	7.79%	-0.92%
Gross Profit Margin	82.74%	83.1%	82.8%
Selling, General & Admin	$2.188B	$2.209B	$2.142B
YoY Change	-1.66%	3.13%	-1.38%
% of Gross Profit	54.45%	54.32%	56.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$201.0M	$209.0M	$215.0M
YoY Change	-13.73%	-2.79%	4.88%
% of Gross Profit	5.0%	5.14%	5.7%
Operating Expenses	$3.418B	$3.469B	$3.415B
YoY Change	-3.15%	1.58%	0.06%
Operating Profit	$600.0M	$1.014B	$271.0M
YoY Change	6.76%	274.17%	-10.26%
Interest Expense	-$144.0M	$227.0M	$263.0M
YoY Change	-18.18%	-13.69%	7.79%
% of Operating Profit	-24.0%	22.39%	97.05%
Other Income/Expense, Net	-$2.000M	$7.000M	$0.00
YoY Change	0.0%		-100.0%
Pretax Income	$528.0M	$774.0M	-$304.0M
YoY Change	-21.89%	-354.61%	143.2%
Income Tax	$108.0M	$197.0M	-$197.0M
% Of Pretax Income	20.45%	25.45%
Net Earnings	$249.0M	$578.0M	-$106.0M
YoY Change	-54.4%	-645.28%	-27.4%
Net Earnings / Revenue	5.13%	11.81%	-2.33%
Basic Earnings Per Share		$4.19	-$1.86
Diluted Earnings Per Share	$2.287M	$4.13	-$1.86
COMMON SHARES
Basic Shares Outstanding	107.1M shares	107.1M shares	105.3M shares
Diluted Shares Outstanding		108.8M shares	105.3M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.364B	$2.292B	$3.300B
YoY Change	-3.35%	-30.55%	950.96%
Cash & Equivalents	$2.364B	$2.292B	$3.300B
Short-Term Investments
Other Short-Term Assets	$1.557B	$1.495B	$1.292B
YoY Change	3.59%	15.71%	-6.24%
Inventory	$384.0M	$376.0M	$349.0M
Prepaid Expenses	$252.0M
Receivables	$2.770B	$2.742B	$2.479B
Other Receivables	$0.00	$0.00	$2.000M
Total Short-Term Assets	$7.075B	$6.905B	$7.808B
YoY Change	-1.01%	-11.57%	63.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.427B	$6.162B	$6.618B
YoY Change	-3.96%	-6.89%	-5.47%
Goodwill	$9.261B	$8.662B	$7.302B
YoY Change	5.14%	18.63%	-0.18%
Intangibles	$1.497B	$1.480B	$1.578B
YoY Change	-6.44%	-6.21%	-2.59%
Long-Term Investments	$1.806B	$2.564B	$2.445B
YoY Change	76.37%	4.87%	66.67%
Other Assets	$65.00M	$140.0M	$436.0M
YoY Change	-80.0%	-67.89%	73.02%
Total Long-Term Assets	$20.50B	$19.01B	$18.38B
YoY Change	2.73%	3.42%	-1.02%
TOTAL ASSETS
Total Short-Term Assets	$7.075B	$6.905B	$7.808B
Total Long-Term Assets	$20.50B	$19.01B	$18.38B
Total Assets	$27.58B	$25.91B	$26.19B
YoY Change	1.75%	-1.05%	12.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.300B	$1.100B	$1.025B
YoY Change	7.71%	7.32%	-8.89%
Accrued Expenses	$1.099B	$1.333B	$1.052B
YoY Change	-7.65%	26.71%	-16.11%
Deferred Revenue	$959.0M	$1.218B	$1.500B
YoY Change	45.52%	-18.8%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$135.0M	$125.0M	$155.0M
YoY Change	-6.9%	-19.35%	-6.06%
Total Short-Term Liabilities	$5.109B	$5.379B	$5.843B
YoY Change	5.41%	-7.94%	48.75%
LONG-TERM LIABILITIES
Long-Term Debt	$15.51B	$14.01B	$15.56B
YoY Change	-0.4%	-9.97%	4.73%
Other Long-Term Liabilities	$1.439B	$1.592B	$1.564B
YoY Change	-11.01%	1.79%	11.32%
Total Long-Term Liabilities	$1.439B	$1.592B	$1.564B
YoY Change	-11.01%	1.79%	11.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.109B	$5.379B	$5.843B
Total Long-Term Liabilities	$1.439B	$1.592B	$1.564B
Total Liabilities	$23.32B	$22.23B	$24.19B
YoY Change	-3.7%	-8.09%	13.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.214B	-$1.463B	-$2.542B
YoY Change	-42.95%	-42.45%	2.96%
Common Stock	$8.000M	$8.000M	$7.000M
YoY Change	14.29%	14.29%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.028B	$722.0M	-$374.0M
YoY Change
Total Liabilities & Shareholders Equity	$27.58B	$25.91B	$26.19B
YoY Change	1.75%	-1.05%	12.12%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q3
OPERATING ACTIVITIES
Net Income	$249.0M	$578.0M	-$106.0M
YoY Change	-54.4%	-645.28%	-27.4%
Depreciation, Depletion And Amortization	$201.0M	$209.0M	$215.0M
YoY Change	-13.73%	-2.79%	4.88%
Cash From Operating Activities	$357.0M	$432.0M	$593.0M
YoY Change	-19.96%	-27.15%	41.53%
INVESTING ACTIVITIES
Capital Expenditures	-$304.0M	$111.0M	$86.00M
YoY Change	83.13%	29.07%	-44.87%
Acquisitions
YoY Change
Other Investing Activities	-$1.212B	$1.108B	-$31.00M
YoY Change	16.99%	-3674.19%	-193.94%
Cash From Investing Activities	-$1.516B	$997.0M	-$117.0M
YoY Change	26.12%	-952.14%	-4.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.231B	-1.331B	-690.0M
YoY Change	-1356.12%	92.9%	198.7%
NET CHANGE
Cash From Operating Activities	357.0M	432.0M	593.0M
Cash From Investing Activities	-1.516B	997.0M	-117.0M
Cash From Financing Activities	1.231B	-1.331B	-690.0M
Net Change In Cash	72.00M	98.00M	-214.0M
YoY Change	-108.43%	-145.79%	-429.23%
FREE CASH FLOW
Cash From Operating Activities	$357.0M	$432.0M	$593.0M
Capital Expenditures	-$304.0M	$111.0M	$86.00M
Free Cash Flow	$661.0M	$321.0M	$507.0M
YoY Change	8.01%	-36.69%	92.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000070318
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-7293
	dei	Entity Registrant Name EntityRegistrantName	TENET HEALTHCARE CORP
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-2557091
	dei	Entity Address Address Line1 EntityAddressAddressLine1	14201 Dallas Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75254
	dei	City Area Code CityAreaCode	469
	dei	Local Phone Number LocalPhoneNumber	893-2200
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	107125882	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2292000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2446000000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2742000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2690000000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	376000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	368000000	USD
CY2021Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	140000000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1495000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1503000000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	6905000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	7147000000	USD
CY2021Q3	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2564000000	USD
CY2020Q4	us-gaap	Long Term Investments And Receivables Net LongTermInvestmentsAndReceivablesNet	2534000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	140000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	325000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5872000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6043000000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6162000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	6692000000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	8662000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8808000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1326000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1284000000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1480000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1600000000	USD
CY2021Q3	us-gaap	Assets Assets	25913000000	USD
CY2020Q4	us-gaap	Assets Assets	27106000000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	125000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	145000000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1100000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1207000000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1071000000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	942000000	USD
CY2021Q3	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	268000000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	243000000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	262000000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	248000000	USD
CY2021Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	70000000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1218000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	659000000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1335000000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1333000000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5379000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4847000000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14009000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15574000000	USD
CY2021Q3	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	762000000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	735000000	USD
CY2021Q3	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	444000000	USD
CY2020Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent	497000000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	29000000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	15000000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	918000000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1592000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1617000000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	22230000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	24217000000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	2048000000	USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	1952000000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	262500000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155402362	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	154407524	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	8000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7000000	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4862000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4844000000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-274000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-281000000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1463000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2128000000	USD
CY2021Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48333196	shares
CY2020Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	48337947	shares
CY2021Q3	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2411000000	USD
CY2020Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	2414000000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	722000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	28000000	USD
CY2021Q3	us-gaap	Minority Interest MinorityInterest	913000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	909000000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1635000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25913000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27106000000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4894000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4557000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14629000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12725000000	USD
CY2021Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	3000000	USD
CY2020Q3	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	-66000000	USD
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	53000000	USD
	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	445000000	USD
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	44000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	103000000	USD
CY2021Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2209000000	USD
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2142000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6690000000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6193000000	USD
CY2021Q3	us-gaap	Supplies Expense SuppliesExpense	827000000	USD
CY2020Q3	us-gaap	Supplies Expense SuppliesExpense	784000000	USD
	us-gaap	Supplies Expense SuppliesExpense	2490000000	USD
	us-gaap	Supplies Expense SuppliesExpense	2158000000	USD
CY2021Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1051000000	USD
CY2020Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1058000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3177000000	USD
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3054000000	USD
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	215000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	624000000	USD
CY2021Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	15000000	USD
CY2020Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	57000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	166000000	USD
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-29000000	USD
CY2020Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-9000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-13000000	USD
CY2021Q3	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	412000000	USD
CY2020Q3	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	1000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	427000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	4000000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	1014000000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	271000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	2120000000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1069000000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	227000000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	263000000	USD
	us-gaap	Interest Expense InterestExpense	702000000	USD
	us-gaap	Interest Expense InterestExpense	761000000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-312000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5000000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	197000000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-197000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-227000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	577000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-107000000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	1057000000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	222000000	USD
CY2021Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	1000000	USD
CY2020Q3	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	1000000	USD
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax	0	USD
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000000	USD
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	1000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2021Q3	us-gaap	Profit Loss ProfitLoss	578000000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-106000000	USD
	us-gaap	Profit Loss ProfitLoss	1057000000	USD
	us-gaap	Profit Loss ProfitLoss	222000000	USD
CY2021Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	129000000	USD
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	90000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	392000000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	237000000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	449000000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-196000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	665000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	448000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-197000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	665000000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15000000	USD
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1000000	USD
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	1000000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	449000000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-196000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	665000000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.18
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.87
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.23
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.19
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.86
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.12
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.87
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.13
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.14
CY2021Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
CY2020Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.13
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.86
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107050000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105263000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106727000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104803000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108761000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105263000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108465000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104803000	shares
CY2021Q3	us-gaap	Profit Loss ProfitLoss	578000000	USD
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-106000000	USD
	us-gaap	Profit Loss ProfitLoss	1057000000	USD
	us-gaap	Profit Loss ProfitLoss	222000000	USD
CY2021Q3	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	2000000	USD
CY2020Q3	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	2000000	USD
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	8000000	USD
	thc	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Amortization Of Net Actuarial Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAmortizationOfNetActuarialGainLossArisingDuringPeriodBeforeTax	6000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	1000000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	0	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	3000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	9000000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	7000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2000000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	6000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	581000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-102000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1064000000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	228000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	129000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	90000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	392000000	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	237000000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	452000000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-192000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	672000000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9000000	USD
	us-gaap	Profit Loss ProfitLoss	1057000000	USD
	us-gaap	Profit Loss ProfitLoss	222000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	624000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	183000000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-246000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	43000000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	38000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	166000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-13000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	427000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	4000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-10000000	USD
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	11000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	25000000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	30000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	23000000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	202000000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-280000000	USD
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	111000000	USD
	thc	Increase Decrease In Inventories And Other Assets Current IncreaseDecreaseInInventoriesAndOtherAssetsCurrent	-30000000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-67000000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-9000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-149000000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1546000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	8000000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	205000000	USD
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	116000000	USD
	thc	Payments For Restructuring And Litigation Costs PaymentsForRestructuringAndLitigationCosts	252000000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1211000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2961000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	354000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	374000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	64000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	61000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1235000000	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	13000000	USD
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	18000000	USD
	thc	Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets	44000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	23000000	USD
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	41000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	10000000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-13000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	802000000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-406000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	740000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	740000000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3183000000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	3244000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	1413000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	3815000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	15000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	48000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	316000000	USD
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	184000000	USD
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	14000000	USD
	us-gaap	Proceeds From Sale Of Interest In Corporate Unit ProceedsFromSaleOfInterestInCorporateUnit	7000000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	19000000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	34000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	11000000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	13000000	USD
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	-8000000	USD
	thc	Proceeds From Grants From Affiliates Net Of Recoupment ProceedsFromGrantsFromAffiliatesNetOfRecoupment	150000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-64000000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	8000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2167000000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	483000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-154000000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3038000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2446000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	262000000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2292000000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3300000000	USD
	us-gaap	Interest Paid Net InterestPaidNet	664000000	USD
	us-gaap	Interest Paid Net InterestPaidNet	757000000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-54000000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-10000000	USD
	thc	Number Of Hospitals Operated By Subsidiaries NumberOfHospitalsOperatedBySubsidiaries	60	hospital
	thc	Number Of Healthcare Facilities NumberOfHealthcareFacilities	460	outpatientCenter
CY2021Q3	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	2000000	USD
	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	65000000	USD
CY2020Q3	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	178000000	USD
	thc	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	890000000	USD
CY2021Q3	us-gaap	Deferred Revenue DeferredRevenue	3000000	USD
CY2020Q4	us-gaap	Deferred Revenue DeferredRevenue	18000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2292000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2446000000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	51000000	USD
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	81000000	USD
	thc	Finance Lease Right Of Use Assets Acquired FinanceLeaseRightOfUseAssetsAcquired	75000000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	93000000	USD
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	121000000	USD
	thc	Operating Lease Right Of Use Assets Acquired OperatingLeaseRightOfUseAssetsAcquired	135000000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2806000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1326000000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1480000000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	2884000000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1284000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1600000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	796000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	53000000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	124000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	110000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	98000000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	83000000	USD
CY2021Q3	thc	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	328000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	139000000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	127000000	USD
	thc	Percentage Investee Results Reflected PercentageInvesteeResultsReflected	1
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2742000000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2690000000	USD
CY2021Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	206000000	USD
CY2020Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	195000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	581000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	579000000	USD
CY2021Q3	thc	Contract With Customer Asset Percentage To Be Reclassified To Receivable Within90 Days ContractWithCustomerAssetPercentageToBeReclassifiedToReceivableWithin90Days	0.91
CY2021Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1000000	USD
CY2020Q3	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	13000000	USD
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3000000	USD
CY2021Q3	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	23000000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	24000000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	48000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	6000000	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	8000000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	19000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	166000000	USD
	us-gaap	Restructuring Costs RestructuringCosts	155000000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3000000	USD
	us-gaap	Severance Costs1 SeveranceCosts1	53000000	USD
	us-gaap	Business Exit Costs1 BusinessExitCosts1	15000000	USD
	us-gaap	Other Restructuring Costs OtherRestructuringCosts	24000000	USD
CY2021Q3	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	372000000	USD
CY2020Q4	thc	Finance Leases And Mortgage Notes FinanceLeasesAndMortgageNotes	403000000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	142000000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	176000000	USD
CY2021Q3	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	14134000000	USD
CY2020Q4	us-gaap	Debt And Capital Lease Obligations DebtAndCapitalLeaseObligations	15719000000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	125000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	145000000	USD
CY2021Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	14009000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15574000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	43000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1000000	USD
	thc	Number Of Frozen Non Qualified Defined Benefit Pension Plans NumberOfFrozenNonQualifiedDefinedBenefitPensionPlans	1	plan
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	937000000	USD
CY2021Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	141000000	USD
CY2021Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	61000000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1000000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	3000000	USD
CY2021Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-9000000	USD
CY2021Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	12000000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1016000000	USD
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	177000000	USD
CY2021Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	43000000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5000000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	USD
CY2021Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	3000000	USD
CY2021Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	15000000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1169000000	USD
CY2021Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	505000000	USD
CY2021Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	51000000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	3000000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	4000000	USD
CY2021Q3	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	3000000	USD
CY2021Q3	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	10000000	USD
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1635000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	437000000	USD
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	125000000	USD
CY2020Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	40000000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1000000	USD
CY2020Q1	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	-15000000	USD
CY2020Q1	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	10000000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	503000000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	123000000	USD
CY2020Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	8000000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2000000	USD
CY2020Q2	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	0	USD
CY2020Q2	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	16000000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	633000000	USD
CY2020Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-148000000	USD
CY2020Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46000000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4000000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	1000000	USD
CY2020Q3	thc	Adjustments To Additional Paid In Capital Purchase Sale Of Joint Venture Interest AdjustmentsToAdditionalPaidInCapitalPurchaseSaleOfJointVentureInterest	62000000	USD
CY2020Q3	thc	Shares Issued And Share Based Compensation Expense Value Share Based Payment Arrangement After Forfeiture SharesIssuedAndShareBasedCompensationExpenseValueShareBasedPaymentArrangementAfterForfeiture	18000000	USD
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	522000000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	26000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	USD
	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	44000000	USD
	thc	Loss Contingency Accrual Other LossContingencyAccrualOther	-5000000	USD
CY2021Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	41000000	USD
CY2019Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	86000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-13000000	USD
	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	84000000	USD
	thc	Loss Contingency Accrual Other LossContingencyAccrualOther	0	USD
CY2020Q3	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	15000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	163000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-64000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	286000000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	29000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6000000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	56000000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	9000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	26000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	18000000	USD
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	79000000	USD
	us-gaap	Income Tax Reconciliation Minority Interest Income Expense IncomeTaxReconciliationMinorityInterestIncomeExpense	48000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	28000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	35000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	0	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	0	USD
	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-3000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4000000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-113000000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-201000000	USD
CY2021Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4000000	USD
CY2020Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3000000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9000000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	197000000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-197000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	303000000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-227000000	USD
	thc	Income Tax Expense Benefit Cares Act IncomeTaxExpenseBenefitCARESAct	-88000000	USD
	thc	Income Tax Expense Benefit Due To Increase Decrease In Liabilities For Uncertain Tax Positions IncomeTaxExpenseBenefitDueToIncreaseDecreaseInLiabilitiesForUncertainTaxPositions	0	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	29000000	USD
CY2021Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	0	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	448000000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107050000	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	4.18
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1711000	shares
CY2021Q3	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.06
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	448000000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108761000	shares
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	4.12
CY2020Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-197000000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105263000	shares
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.87
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020Q3	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	0
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-197000000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105263000	shares
CY2020Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.87
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	665000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106727000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	6.23
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1738000	shares
	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	-0.10
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	665000000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108465000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	6.13
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-15000000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	104803000	shares
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.14
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	thc	Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount	0
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15000000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	104803000	shares
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.14
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	623000000	USD
CY2021Q3	us-gaap	Assets Assets	25913000000	USD
CY2020Q4	us-gaap	Assets Assets	27106000000	USD
CY2021Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	111000000	USD
CY2020Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	354000000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	374000000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4894000000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4557000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14629000000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12725000000	USD
CY2021Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	45000000	USD
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	44000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	141000000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	103000000	USD
CY2021Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	855000000	USD
CY2020Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	551000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2466000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1868000000	USD
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	215000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	624000000	USD
CY2021Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	855000000	USD
CY2020Q3	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	551000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	2466000000	USD
	thc	Adjusted Earnings Before Interest Tax Depreciation And Amortization AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization	1868000000	USD
CY2021Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	209000000	USD
CY2020Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	215000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	654000000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	624000000	USD
CY2021Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	15000000	USD
CY2020Q3	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	57000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	55000000	USD
	thc	Restructuring Settlement Impairment Provisions And Acquisition Cost RestructuringSettlementImpairmentProvisionsAndAcquisitionCost	166000000	USD
CY2021Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-29000000	USD
CY2020Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-9000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-64000000	USD
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-13000000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	227000000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	263000000	USD
	us-gaap	Interest Expense InterestExpense	702000000	USD
	us-gaap	Interest Expense InterestExpense	761000000	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-312000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-74000000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-316000000	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3000000	USD
CY2021Q3	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	412000000	USD
CY2020Q3	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	1000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	427000000	USD
	thc	Net Gainon Sale Consolidation And Deconsolidation Of Facilities NetGainonSaleConsolidationAndDeconsolidationOfFacilities	4000000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	774000000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-304000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1360000000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5000000	USD
CY2021Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	206000000	USD
CY2020Q3	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	195000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	581000000	USD
	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	579000000	USD

Files In Submission

Name	View Source	Status
0000070318-21-000040-index-headers.html	Edgar Link	pending
0000070318-21-000040-index.html	Edgar Link	pending
0000070318-21-000040.txt	Edgar Link	pending
0000070318-21-000040-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thc-20210930.htm	Edgar Link	pending
thc-20210930.xsd	Edgar Link	pending
thc-20210930ex31a.htm	Edgar Link	pending
thc-20210930ex31b.htm	Edgar Link	pending
thc-20210930ex32.htm	Edgar Link	pending
thc-20210930_cal.xml	Edgar Link	unprocessable
thc-20210930_def.xml	Edgar Link	unprocessable
thc-20210930_htm.xml	Edgar Link	completed
thc-20210930_lab.xml	Edgar Link	unprocessable
thc-20210930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THC
TENET HEALTHCARE CORP Stock $thc

2021 Q4 Form 10-Q Financial Statement

#000007031821000040 Filed on October 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC TENET HEALTHCARE CORP Stock $thc

2021 Q4 Form 10-Q Financial Statement

#000007031821000040 Filed on October 29, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THC
TENET HEALTHCARE CORP Stock $thc